Found: 6
Select item for more details and to access through your institution.
A multi-center randomized proof-of-concept clinical trial applying [¹⁸F]FDG-PET for evaluation of metabolic therapy with rosiglitazone XR in mild to moderate Alzheimer's disease.
- Published in:
- 2010
- By:
- Publication type:
- journal article
A Multi-Center Randomized Proof-of-Concept Clinical Trial Applying [<sup>18</sup>F]FDG-PET for Evaluation of Metabolic Therapy with Rosiglitazone XR in Mild to Moderate Alzheimer's Disease.
- Published in:
- Journal of Alzheimer's Disease, 2010, v. 22, n. 4, p. 1241, doi. 10.3233/JAD-2010-100939
- By:
- Publication type:
- Article
Prosthetic Hip Infection and Bacteremia Due to Campylobacter jejuni in a Patient with AIDS.
- Published in:
- Clinical Infectious Diseases, 1993, v. 16, n. 3, p. 439
- By:
- Publication type:
- Article
Persuasive Messages.
- Published in:
- Marketing Health Services, 1998, v. 18, n. 4, p. 32
- By:
- Publication type:
- Article
Effects of 12 months of treatment with the PPARγ agonist rosiglitazone on brain glucose metabolism in Alzheimer's Disease: A <sup>18</sup>F-FDG PET study
- Published in:
- 2009
- By:
- Publication type:
- Abstract
Effects of 12 months of treatment with the PPARγ agonist rosiglitazone on brain glucose metabolism in Alzheimer's disease: A <sup>18</sup>F-FDG PET study
- Published in:
- 2009
- By:
- Publication type:
- Abstract